Validity and representativeness of the "Disease Analyzer" patient database for use in pharmacoepidemiological and pharmacoeconomic studies.

@article{Becher2009ValidityAR,
  title={Validity and representativeness of the "Disease Analyzer" patient database for use in pharmacoepidemiological and pharmacoeconomic studies.},
  author={Heiko Becher and Karel Kostev and Detlef Schr{\"o}der-Bernhardi},
  journal={International journal of clinical pharmacology and therapeutics},
  year={2009},
  volume={47 10},
  pages={
          617-26
        }
}
OBJECTIVES Patient and health care databases are available in many countries. These are often based on routinely collected diagnosis and prescription data. Various research questions, such as those related to pharmacoepidemiological health services or drug supply, can be evaluated on the basis of these databases. In Germany, the Disease Analyzer patient database is the largest database of its kind. Using various validity criteria, the representativeness of this database is examined with respect… CONTINUE READING
BETA

Citations

Publications citing this paper.
SHOWING 1-10 OF 107 CITATIONS

FILTER CITATIONS BY YEAR

2010
2019

CITATION STATISTICS

  • 36 Highly Influenced Citations

  • Averaged 18 Citations per year over the last 3 years

Similar Papers

Loading similar papers…